Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT02147990

Public ClinicalTrials.gov record NCT02147990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)

Study identification

NCT ID
NCT02147990
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Clovis Oncology, Inc.
Industry
Enrollment
318 participants

Conditions and interventions

Interventions

  • Rociletinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2014
Primary completion
Jul 29, 2019
Completion
Aug 26, 2019
Last update posted
Aug 11, 2020

2014 – 2019

United States locations

U.S. sites
41
U.S. states
15
U.S. cities
39
Facility City State ZIP Site status
UCLA Medical Center Alhambra California 91801
Comprehensive Blood and Cancer Center Bakersfield California 93309
Saint Jude Heritage Healthcare Fullerton California 92835
University of California San Diego Moores Cancer Center La Jolla California 92093
Northridge Hospital Medical Center Northridge California 91328
Cancer Care Associates Redondo Beach California 90277
University of California Davis Medical Center Sacramento California 95817
University of California San Francisco San Francisco California 94115
Coastal Integrative Cancer Care San Luis Obispo California 93401
Saint Mary's Regional Cancer Center Grand Junction Colorado 81501-6132
Rocky Mountain Cancer Centers, LLP Lone Tree Colorado 80218
Yale University School of Medicine New Haven Connecticut 32135
Advanced Medical Specialties Miami Florida 33176
Cleveland Clinic Florida Weston Florida 33331
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
University of Illinois Chicago Chicago Illinois 60612
Illinois Cancer Specialists Niles Illinois 60714
Beth Israel Comprehensive Cancer Center Boston Massachusetts 02215
Lahey Hospital and Medical Center Burlington Massachusetts 01805
Minnesota Oncology Hematology, P.A Minneapolis Minnesota 55404
Mayo Clinic - Rochester Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
New York Oncology Hematology, PC Latham New York 12110-2188
University of Rochester Rochester New York 14642
Montefiore Medical Center The Bronx New York 10461
University Hospitals of Cleveland Cleveland Ohio 44106
Cleveland Clinic Cleveland Ohio 44195
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Tennessee Oncology, PLLC Nashville Tennessee 37203
Texas Oncology P.A. Amarillo Texas 79106
USO - Texas Oncology P.A. Arlington Texas 76014
Texas Oncology-Austin Central Austin Texas 78705
Texas Oncology-Beaumont Beaumont Texas 77702
Texas Oncology P.A. Bedford Texas 76022
Texas Oncology P.A. Dallas Texas 75246
Texas Oncology P.A. Flower Mound Texas 75028
The Methodist Hospital Houston Texas 77030
Texas Oncology - Plano East Plano Texas 75075-7787
Virginia Cancer Specialists Fairfax Virginia 22031
Northwest Cancer Specialists, P.C. Vancouver Washington 98686
Yakima Valley Memorial Hospital, North Star Lodge Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02147990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2020 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02147990 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →